NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,288,000 | +39.7% | 17,340 | +37.0% | 1.52% | +2.1% |
Q4 2016 | $922,000 | +40.8% | 12,657 | +52.6% | 1.49% | +35.0% |
Q3 2016 | $655,000 | +7.7% | 8,295 | +12.6% | 1.10% | +4.3% |
Q2 2016 | $608,000 | +14.1% | 7,364 | 0.0% | 1.06% | +163.3% |
Q1 2016 | $533,000 | -17.0% | 7,364 | -1.2% | 0.40% | -20.0% |
Q4 2015 | $642,000 | -6.3% | 7,456 | 0.0% | 0.50% | -9.2% |
Q3 2015 | $685,000 | -6.5% | 7,456 | 0.0% | 0.55% | +2.6% |
Q2 2015 | $733,000 | -0.3% | 7,456 | 0.0% | 0.54% | -2.7% |
Q1 2015 | $735,000 | +3.8% | 7,456 | -2.4% | 0.55% | -3.0% |
Q4 2014 | $708,000 | -5.9% | 7,639 | -4.4% | 0.57% | -8.1% |
Q3 2014 | $752,000 | +4.0% | 7,989 | 0.0% | 0.62% | +6.7% |
Q2 2014 | $723,000 | +63.9% | 7,989 | +54.0% | 0.58% | +57.5% |
Q1 2014 | $441,000 | +0.2% | 5,189 | -5.2% | 0.37% | 0.0% |
Q4 2013 | $440,000 | +2.3% | 5,474 | -2.4% | 0.37% | -6.6% |
Q3 2013 | $430,000 | +338.8% | 5,607 | +305.7% | 0.40% | +311.5% |
Q2 2013 | $98,000 | – | 1,382 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |